Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval of Cimzia in new indication

Sep. 25, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Kineret receives positive CHMP opinion for cryopyrin-associated periodic syndromes

Sep. 25, 2013

EMA committee recommends approval of Xofigo injection for CRPC

Sep. 23, 2013

Trastuzumab emtansine receives committee recommendation in E.U.

Sep. 23, 2013

CHMP recommends E.U. approval of canagliflozin

Sep. 23, 2013

Novo Nordisk's NovoEight gets positive opinion in E.U.

Sep. 23, 2013

Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena

Sep. 23, 2013

EMA committee issues positive opinion on AstraZeneca's four-strain flu vaccine

Sep. 23, 2013

Relvar Ellipta receives approval in Japan, recommendation in Europe

Sep. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...